276 related articles for article (PubMed ID: 25136622)
1. Preclinical and clinical effects of mistletoe against breast cancer.
Marvibaigi M; Supriyanto E; Amini N; Abdul Majid FA; Jaganathan SK
Biomed Res Int; 2014; 2014():785479. PubMed ID: 25136622
[TBL] [Abstract][Full Text] [Related]
2. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
[TBL] [Abstract][Full Text] [Related]
3. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.
Kienle GS; Glockmann A; Schink M; Kiene H
J Exp Clin Cancer Res; 2009 Jun; 28(1):79. PubMed ID: 19519890
[TBL] [Abstract][Full Text] [Related]
4. Mistletoe therapy in oncology.
Horneber MA; Bueschel G; Huber R; Linde K; Rostock M
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD003297. PubMed ID: 18425885
[TBL] [Abstract][Full Text] [Related]
5. [Favourable course of persisting malignant ascites].
Stange R; Jänsch A; Schrag S; Pflugbeil C; Schlodder D; Pandey-Hoffmann U; Uehleke B
Forsch Komplementmed; 2009 Feb; 16(1):49-53. PubMed ID: 19295230
[TBL] [Abstract][Full Text] [Related]
6. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
7. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of NK cell activity against autologous tumour cells and K562 cells with the clinical outcome during therapy with mistletoe extracts].
Schink M; Tröger W; Goyert A; Scheuerecker H; Selbmann HK; Glaser F
Forsch Komplementmed; 2006 Jun; 13(3):147-55. PubMed ID: 16868360
[TBL] [Abstract][Full Text] [Related]
9. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts.
Kienle GS; Kiene H
Eur J Med Res; 2007 Mar; 12(3):103-19. PubMed ID: 17507307
[TBL] [Abstract][Full Text] [Related]
10. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
[TBL] [Abstract][Full Text] [Related]
11. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
12. Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
Steigenberger C; Schnell-Inderst P; Flatscher-Thöni M; Plank LM; Siebert U
Eur J Oncol Nurs; 2023 Aug; 65():102338. PubMed ID: 37321128
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
[TBL] [Abstract][Full Text] [Related]
14. Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research.
Rostock M; Huber R
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():18-22. PubMed ID: 15353898
[TBL] [Abstract][Full Text] [Related]
15. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
[TBL] [Abstract][Full Text] [Related]
16. Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study.
Beuth J; Schneider B; Schierholz JM
Anticancer Res; 2008; 28(1B):523-7. PubMed ID: 18383896
[TBL] [Abstract][Full Text] [Related]
17. [Mistletoe in the treatment of cancer patients].
Rostock M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
Eisenbraun J; Scheer R; Kröz M; Schad F; Huber R
Phytomedicine; 2011 Jan; 18(2-3):151-7. PubMed ID: 20724129
[TBL] [Abstract][Full Text] [Related]
19. Mistletoe Extract Targets the STAT3-FOXM1 Pathway to Induce Apoptosis and Inhibits Metastasis in Breast Cancer Cells.
Kwon YS; Chun SY; Kim MK; Nan HY; Lee C; Kim S
Am J Chin Med; 2021; 49(2):487-504. PubMed ID: 33622211
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
